ANDREUCCI, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 3.235
EU - Europa 2.617
AS - Asia 2.032
SA - Sud America 288
Continente sconosciuto - Info sul continente non disponibili 80
AF - Africa 47
OC - Oceania 24
Totale 8.323
Nazione #
US - Stati Uniti d'America 3.152
PL - Polonia 782
RU - Federazione Russa 738
CN - Cina 577
IT - Italia 506
SG - Singapore 467
HK - Hong Kong 274
BR - Brasile 216
VN - Vietnam 202
KR - Corea 162
IE - Irlanda 136
FI - Finlandia 102
BD - Bangladesh 83
IN - India 77
SE - Svezia 74
FR - Francia 60
DE - Germania 59
GB - Regno Unito 53
CA - Canada 52
ID - Indonesia 43
JO - Giordania 41
JP - Giappone 31
AR - Argentina 23
AU - Australia 22
NL - Olanda 20
CH - Svizzera 18
BE - Belgio 14
EC - Ecuador 14
ZA - Sudafrica 14
ES - Italia 12
AT - Austria 10
CZ - Repubblica Ceca 10
PK - Pakistan 10
CO - Colombia 9
CI - Costa d'Avorio 8
MX - Messico 8
TR - Turchia 8
UA - Ucraina 8
CL - Cile 7
TH - Thailandia 7
UZ - Uzbekistan 7
EG - Egitto 6
NG - Nigeria 6
VE - Venezuela 6
CR - Costa Rica 5
IL - Israele 5
PH - Filippine 5
PY - Paraguay 5
SK - Slovacchia (Repubblica Slovacca) 5
AE - Emirati Arabi Uniti 4
IQ - Iraq 4
JM - Giamaica 4
MY - Malesia 4
UY - Uruguay 4
DO - Repubblica Dominicana 3
HN - Honduras 3
KZ - Kazakistan 3
MA - Marocco 3
MO - Macao, regione amministrativa speciale della Cina 3
PE - Perù 3
SY - Repubblica araba siriana 3
BJ - Benin 2
LB - Libano 2
LK - Sri Lanka 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
SN - Senegal 2
TN - Tunisia 2
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
IR - Iran 1
KE - Kenya 1
KW - Kuwait 1
MQ - Martinica 1
MT - Malta 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
ST - Sao Tome e Principe 1
SV - El Salvador 1
TW - Taiwan 1
VC - Saint Vincent e Grenadine 1
Totale 8.243
Città #
Warsaw 782
Santa Clara 653
Ashburn 476
Singapore 378
Hong Kong 237
Fairfield 214
San Jose 207
Seoul 161
Hefei 154
Chandler 147
Dublin 136
Florence 108
Beijing 105
Seattle 85
Woodbridge 80
Houston 73
Council Bluffs 72
Milan 69
Helsinki 61
Ho Chi Minh City 61
Cambridge 59
Wilmington 59
Los Angeles 49
Ann Arbor 46
Buffalo 45
Moscow 43
Hanoi 40
Lauterbourg 38
New York 36
Altamura 35
Lawrence 35
Dallas 33
Jakarta 33
Kent 31
Rome 31
The Dalles 31
Dong Ket 30
Munich 29
Princeton 29
Shanghai 26
Phoenix 25
Boston 23
Turku 23
Pune 21
Mumbai 20
Tokyo 20
São Paulo 19
Boardman 17
Melbourne 17
Clifton 16
London 16
Toronto 15
Lappeenranta 14
Chicago 13
Naples 13
Pisa 13
San Diego 13
Shenzhen 12
Falls Church 11
Bengaluru 10
Bern 10
Bologna 10
Guangzhou 10
Montreal 10
Orem 10
Turin 10
Chennai 9
Abidjan 8
Medford 8
Redondo Beach 8
Tianjin 8
West Jordan 8
Atlanta 7
Brescia 7
Da Nang 7
Frankfurt am Main 7
Paris 7
Tashkent 7
Vienna 7
Washington 7
Abuja 6
Amsterdam 6
Arezzo 6
Bangkok 6
Bari 6
Brussels 6
Gavirate 6
Lahore 6
New Delhi 6
Rio de Janeiro 6
Brasília 5
Bratislava 5
Catania 5
Charlotte 5
Denver 5
Figino 5
Fortaleza 5
Ghent 5
Guayaquil 5
Haiphong 5
Totale 5.623
Nome #
Acidity of Microenvironment as a Further Driver of Tumor Metabolic Reprogramming 419
The acidic microenvironment as a possible niche of dormant tumor cells 325
EGFR/uPAR interaction as druggable target to overcome vemurafenib acquired resistance in melanoma cells 300
Type II CRISPR/Cas9 approach in the oncological therapy 294
Anoikis resistance as a further trait of acidic-adapted melanoma cells 288
A potentiated cooperation of carbonic anhydrase IX and histone deacetylase inhibitors against cancer 272
Oleuropein, the Main Polyphenol of Olea europaea Leaf Extract, Has an Anti-Cancer Effect on Human BRAF Melanoma Cells and Potentiates the Cytotoxicity of Current Chemotherapies 270
Cell-targeted c(AmpRGD)-sunitinib molecular conjugates impair tumor growth of melanoma 263
SOX2 as a novel contributor of oxidative metabolism in melanoma cells 259
The acidic tumor microenvironment drives a stem-like phenotype in melanoma cells 256
Targeting the receptor tyrosine kinase RET in combination with aromatase inhibitors in ER positive breast cancer xenografts 239
Carbonic anhydrase IX inhibition affects viability of cancer cells adapted to extracellular acidosis 215
Everolimus selectively targets vemurafenib resistant BRAFV600E melanoma cells adapted to low pH 209
Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis 209
Potential Role of HLA Class I Antigens in the Glycolytic Metabolism and Motility of Melanoma Cells 190
Local modulation of thyroid hormone signaling in the retina affects the development of diabetic retinopathy 186
An Oleocanthal-Enriched EVO Oil Extract Induces the ROS Production in Gastric Cancer Cells and Potentiates the Effect of Chemotherapy 186
Blockade of Sialylation with Decrease in Polysialic Acid Levels Counteracts Transforming Growth Factor β1-Induced Skin Fibroblast-to-Myofibroblast Transition 185
The CAIX inhibitor SLC-0111 exerts anti-cancer activity on gastric cancer cell lines and resensitizes resistant cells to 5-Fluorouracil, taxane-derived, and platinum-based drugs 184
Extracellular lactic acidosis drives reprogramming of human subcutaneous adipocytes toward pathogenic myofibroblasts 183
The Carbonic Anhydrase IX inhibitor SLC-0111 as emerging agent against the mesenchymal stem cell-derived pro-survival effects on melanoma cells 181
FDG uptake in cancer: a continuing debate 180
Nintedanib-Containing Dual Conjugates Targeting αVβ6 Integrin and Tyrosine Kinase Receptors as Potential Antifibrotic Agents 179
Extracellular Lactic Acidosis of the Tumor Microenvironment Drives Adipocyte-to-Myofibroblast Transition Fueling the Generation of Cancer-Associated Fibroblasts 177
uPAR-expressing melanoma exosomes promote angiogenesis by VE-Cadherin, EGFR and uPAR overexpression and rise of ERK1,2 signaling in endothelial cells 174
CRISPR/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell Lines 174
Skin telocyte secretome as conditioned medium prevents profibrotic differentiation of skin fibroblasts into myofibroblasts 171
Fenotipo Turner associato ad una delezione interstiziale sul braccio lungo del cromosoma 2 167
uPAR knockout results in a deep glycolytic and OXPHOS reprogramming in melanoma and colon carcinoma cell lines 162
FGF2 in Human Melanoma Progression: The Antithetical Functions of Different Isoforms 158
Pharmacological Stimulation of Soluble Guanylate Cyclase Counteracts the Profibrotic Activation of Human Conjunctival Fibroblasts 157
Extracellular Acidosis Differentially Regulates Estrogen Receptor β-Dependent EMT Reprogramming in Female and Male Melanoma Cells 156
Enhanced vasculogenic capacity induced by 5-fluorouracil chemoresistance in a gastric cancer cell line 152
Nintedanib-αVβ6 Integrin Ligand Conjugates Reduce TGFβ-Induced EMT in Human Non-Small Cell Lung Cancer 141
miR-214-enriched extracellular vesicles released by acid-adapted melanoma cells promote inflammatory macrophage-dependent tumor trans-endothelial migration 133
Blockade of sialylation with decrease in polysialic acid levels counteracts transforming growth factor β1-induced skin fibroblast-to-myofibroblast transition 132
Unraveling the Potential of Amino-, Acylamino-, and Ureido-Substituted 3H-1,2-Benzoxaphosphepine 2-Oxides toward Nanomolar Inhibitors of Tumor-Associated Carbonic Anhydrases IX and XII 124
Skin Telocyte Secretome as Conditioned Medium Prevents Profibrotic Differentiation of Skin Fibroblasts into Myofibroblasts 117
uPAR controls vasculogenic mimicry ability expressed by drug-resistant melanoma cells. 117
Oleuropein affects braf melanoma cells and potentiates chemotherapy cytotoxicity 113
Physicochemical aspects of the tumour microenvironment as drivers of vasculogenic mimicry 106
Oleuropein potentiates the cytotoxic activity of dacarbazine against melanoma cells. 102
Ketoconazole-carbonic anhydrase inhibitors as potential anticancer agents 77
Discovery of First-in-Class Carbonic Anhydrase/Histone Deacetylase Dual Inhibitors with Antiproliferative Activity in Cancer Cells 41
Totale 8.323
Categoria #
all - tutte 22.747
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.747


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022167 0 0 8 8 8 14 7 15 7 22 32 46
2022/2023626 46 111 35 47 42 106 73 44 81 7 18 16
2023/2024426 3 29 33 17 21 66 28 106 12 43 32 36
2024/20252.115 64 189 168 343 571 238 37 165 61 41 120 118
2025/20263.015 296 444 324 329 269 92 355 147 188 186 133 252
2026/2027298 104 88 106 0 0 0 0 0 0 0 0 0
Totale 8.323